PETMED EXPRESS INC Financial Summary

Quick Answer

PETMED EXPRESS INC reported Total Revenue of $226.97 million for fiscal year 2025.

PETMED EXPRESS INC — Key Financials by Year

Metric 2025 2024 2023 2022 2021 2020
Total Revenue $226.97M
-17.2%
$274.10M
+10.7%
$247.57M
Revenue (ASC 606) $226.97M
-17.2%
$274.10M
+10.7%
$247.57M
Net Income -$6.27M
+16.0%
-$7.46M
-245.2%
$5.14M
-72.5%
$18.72M
-38.8%
$30.60M
+18.4%
$25.85M
-31.5%
Diluted EPS -$0.30
+18.9%
-$0.37
-248.0%
$0.25
-72.8%
$0.92
-39.5%
$1.52
+17.8%
$1.29
-29.9%
Total Assets $148.70M
-12.5%
$169.88M
+1.4%
$167.48M
-5.0%
$176.32M
-6.0%
$187.50M
+20.7%
$155.32M
+0.6%
Cash and Equivalents $54.72M
-1.0%
$55.30M
-46.9%
$104.09M
-6.3%
$111.08M
-6.4%
$118.72M
+14.4%
$103.76M
+3.2%
Stockholders Equity $85.13M
-12.0%
$96.73M
-12.0%
$109.97M
-10.9%
$123.45M
-1.2%
$124.93M
-3.9%
$130.01M
-3.5%
Operating Income -$1.53M
+81.3%
-$8.16M
-234.9%
$6.05M
-75.1%
$24.29M
-35.4%
$37.59M
+21.3%
$30.98M
-32.9%
Gross Profit $69.14M
-18.4%
$84.77M
+10.8%
$76.50M
-0.6%
$76.94M
-14.5%
$89.95M
+10.7%
$81.25M
-14.8%
Shares Outstanding 20.66M
-2.3%
21.15M
+0.3%
21.08M
+0.5%
20.98M
+3.5%
20.27M
+0.5%
20.17M
-2.5%

Most Recent Quarter

Metric Quarter Ending Value YoY QoQ
Total Revenue December 31, 2025 $40.66M -21.7% -8.3%
Revenue (ASC 606) December 31, 2025 $40.66M -21.7% -8.3%
Net Income December 31, 2025 -$10.55M -1392.6% -23.9%
Diluted EPS December 31, 2025 -$0.50 -1566.7% -22.0%
Total Assets December 31, 2025 $87.97M -39.2% -12.3%
Cash and Equivalents December 31, 2025 $26.91M -46.3% -25.4%
Stockholders Equity December 31, 2025 $32.77M -65.9% -23.9%
Operating Income December 31, 2025 -$10.47M -2226.4% -24.9%
Gross Profit December 31, 2025 $9.46M -41.4% -23.8%
Shares Outstanding December 31, 2025 21.38M +3.5% +1.7%
  • PETMED EXPRESS INC reported Total Revenue of $226.97 million for fiscal year 2025.
  • PETMED EXPRESS INC showed a decrease of -17.2% in Total Revenue compared to the prior fiscal year.
  • PETMED EXPRESS INC reported Revenue (ASC 606) of $226.97 million for fiscal year 2025.
  • PETMED EXPRESS INC showed a decrease of -17.2% in Revenue (ASC 606) compared to the prior fiscal year.
  • PETMED EXPRESS INC reported Net Income of -$6.27 million for fiscal year 2025.
  • PETMED EXPRESS INC showed an increase of +16.0% in Net Income compared to the prior fiscal year.
  • PETMED EXPRESS INC reported Diluted EPS of $0.30 per share (loss) for fiscal year 2025.
  • PETMED EXPRESS INC showed an increase of +18.9% in Diluted EPS compared to the prior fiscal year.
  • PETMED EXPRESS INC reported Total Assets of $148.70 million for fiscal year 2025.
  • PETMED EXPRESS INC showed a decrease of -12.5% in Total Assets compared to the prior fiscal year.
  • PETMED EXPRESS INC reported Cash and Equivalents of $54.72 million for fiscal year 2025.
  • PETMED EXPRESS INC showed a decrease of -1.0% in Cash and Equivalents compared to the prior fiscal year.
  • PETMED EXPRESS INC reported Stockholders Equity of $85.13 million for fiscal year 2025.
  • PETMED EXPRESS INC showed a decrease of -12.0% in Stockholders Equity compared to the prior fiscal year.
  • PETMED EXPRESS INC reported Operating Income of -$1.53 million for fiscal year 2025.
  • PETMED EXPRESS INC showed an increase of +81.3% in Operating Income compared to the prior fiscal year.
  • PETMED EXPRESS INC reported Gross Profit of $69.14 million for fiscal year 2025.
  • PETMED EXPRESS INC showed a decrease of -18.4% in Gross Profit compared to the prior fiscal year.
  • PETMED EXPRESS INC reported Shares Outstanding of 20.66 million shares for fiscal year 2025.
  • PETMED EXPRESS INC showed a decrease of -2.3% in Shares Outstanding compared to the prior fiscal year.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment